Waltz Health and Fresenius Kabi are moving to offer three biosimilars through a direct-to-payer model, bypassing traditional wholesaler and pharmacy benefit manager rebate channels entirely. The partnership represents a significant shift in
A federal district court has delivered a significant ruling that limits the government’s ability to claw back awarded grant funding based on shifting agency priorities. The U.S. District Court for the District
MoreBrown Rudnick has completed the largest group lateral hire in its history, bringing aboard a 34-lawyer intellectual property litigation team from HSF Kramer. The move signals that large-scale group lateral hires remain
MorePrivate companies added only 44,000 jobs in July, falling well short of market expectations and marking a sharp slowdown from the previous month. The figure represents a significant drop from the downwardly
MoreJohnson & Johnson has announced the retirement of Jennifer Taubert, 62, worldwide chair of J&J Innovative Medicine, after more than 21 years with the company. Taubert joined J&J’s executive committee in 2018
MoreElite law firms are being forced to rethink their recruitment strategies as straightforward salary increases no longer persuade the most profitable partners to switch firms. Legal recruiters say that when a partner
MoreNext has upgraded its full-year profit guidance for the third time in 2026, offering fresh hope that UK consumers remain willing to spend despite ongoing household budget pressures. The clothing and homeware
MoreEurope is grappling with a drought so severe that governments are resorting to underwater explosions and emergency military deployments to protect critical energy infrastructure and trade routes. Romania recently shut down its
MoreBeazley (BEZ), the FTSE 100 specialty insurer, has reported a dramatic fall in profits for the first half of 2026, blaming war and escalating global risks for the sharp decline. The London-listed
MoreMerck (MRK) is pushing into one of the pharmaceutical industry’s most closely watched therapeutic categories with its newly developed oral cholesterol treatment, Lipfendra. The drug belongs to the PCSK9 inhibitor class, a
MorePhiladelphia’s Fair Criminal Record Screening Standards Ordinance has been significantly updated, and employers across the city must now navigate a more detailed set of requirements. The Philadelphia Commission on Human Relations issued
More
